Eden Health Acquires Contigo Compounding

August 19, 2025

Eden Health has acquired Contigo Compounding, a licensed 503A compounding pharmacy, to integrate in-house sterile and non-sterile compounding capabilities into its personalized care platform. The acquisition gives Eden direct control of medication preparation and supply chain for faster adjustments, improved adherence, and next-day shipping for members.

Buyers
Eden Health
Targets
Contigo Compounding
Location
New Mexico, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.